William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
O'Reilly Automotive (ORLY) Sales Gain, but Earnings in Check by Cost Pressures - William Blair
-
PPD, Inc. Announces Pricing of its Initial Public Offering
-
Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Kezar Announces Closing of $56.8 Million Public Offering of Common Stock and Pre-Funded Warrants
-
1Life Healthcare (One Medical) Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
1Life Healthcare (One Medical) Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
1Life Healthcare (One Medical) Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Oxford Lane Capital Corp. Announces Preferred Stock Offering
-
Oxford Lane Capital Corp. Announces Preferred Stock Offering
-
Lennox International (LII) Negative Sentiment 'Nearing a Bottom' - William Blair
-
Irish Continental Group plc : Holding(s) in Company
-
UPDATE: William Blair Starts Coupa Software (COUP) at Outperform
-
William Blair Reiterates Outperform Rating on Agile Therapeutics (AGRX)
-
ZMC Partners With Simeio
-
One Medical (ONEM) IPO Opens 29% Higher
-
Kezar Life Sciences (KZR) Prices $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Kezar Announces Pricing of $49.4 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Under Armour, Inc. (UA) Should Beat by a Penny - William Blair
-
U.S. Physical Therapy (USPH) NDR Indicates Trends Remain Strong - William Blair
-
1Life Healthcare (One Medical) Announces Pricing of Initial Public Offering
-
1Life Healthcare (One Medical) Announces Pricing of Initial Public Offering
-
Kezar Life Sciences (KZR) Announces Proposed Common Share Offering
-
Kezar Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Kezar Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Form D/A William Blair China A-Sh
-
Generational Group Announces Refinitiv/Thomson M&A Rankings
-
Starbucks (SBUX) Quarter Overshadowed by Coronavirus - William Blair
-
Royal Caribbean Cruises (RCL) EPS Impact From Coronavirus Likely to be only 3% - William Blair
-
ImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Autolus Announces Closing of Public Offering
-
Autolus Announces Closing of Public Offering
-
PPD, Inc. Announces Launch of its Initial Public Offering
-
Harley-Davidson (HOG) Could Report Better Than Expected Margins - William Blair
-
Adaptive Biotechnologies (ADPT) Prices 8M Share Common Offering at $26.50/Sh
-
Adaptive Announces Pricing of Public Offering of Common Stock
-
Adaptive Announces Pricing of Public Offering of Common Stock
-
ARMOUR Residential REIT, Inc. Prices $75 Million Public Offering of 7.00% Series C Cumulative Redeemable Preferred Stock
-
William Blair Sees Buying Opportunity in Karuna Therapeutics Inc. (KRTX)
-
Netflix (NFLX) Content Spend Creates an Unbreachable Moat - William Blair
-
ARMOUR Residential REIT, Inc. Announces Public Offering of Series C Cumulative Redeemable Preferred Stock
-
National Vision Holdings (EYE) Surprise Walmart Expansion Alleviates Major Overhang for Shares - William Blair
-
Heritage Completes Sale of Portfolio Company, EPTAM Precision Solutions
-
Autolus Therapeutics (AUTL) Prices 7.25M ADS Offering at $11/ADS
-
Immunogen (IMGN) Prices 21.325M Share Common Offering at $4.25/Sh
-
Autolus Announces Pricing of Public Offering
-
Autolus Announces Pricing of Public Offering
-
ImmunoGen Announces Pricing of Public Offering of Common Stock

